Overview

Ultrasound Therapy Market Overview:

FutureWise Market Research has instantiated a report that provides an intricate analysis of Ultrasound Therapy Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.
According to the research study conducted by FutureWise research analysts, the Ultrasound Therapy Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the Ultrasound Therapy Market along with the growth opportunities present across this business vertical.
Major players included in the Ultrasound Therapy Market are 

• Chongqing Haifu Medical Technology Co., Ltd.
•  EDAP TMS S.A.
• SonaCare Medical
• ILJIN Holdings Co., Ltd. (ALPINION MEDICAL SYSTEMS Co., Ltd.)
• Image Guided Therapy S.A.
• Theraclion SA
• Novartis AG (NAG)
• Merz Pharmaceuticals GmbH (Ulthera, Inc.),
• Shanghai A&S Technology Development Co., Ltd

(Note: The list of the major players will be updated with the latest market scenario and trends)

Ultrasound Therapy Market Segmentation:
By Application

• Prostate Cancer
• Uterine Fibroids
• Neurological Disorders
• Aesthetics
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Ultrasound Therapy Market by application, by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America, Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Neurological Disorders offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Ultrasound Therapy Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Ultrasound Therapy Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Ultrasound Therapy Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Ultrasound Therapy Market, By Application Type Historical Analysis and Forecast 2022-2028 (USD Million)  
   7.1. Prostate Cancer
   7.2. Uterine Fibroids
   7.3. Neurological Disorders
   7.4. Aesthetics
   7.5. Others

8. North America Ultrasound Therapy Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   8.1. Introduction
   8.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
        8.2.1. U.S.A
        8.2.2. Canada
        8.2.3. Mexico
   8.3. Market Size (USD Million) Forecast for North America 2022-2028

9. Latin America Ultrasound Therapy Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    9.1. Introduction
    9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         9.2.1. Brazil
         9.2.2. Venezuela
         9.2.3. Argentina
         9.2.4. Rest of Latin America
    9.3. Market Size (USD Million) Forecast for Latin America 2022-2028

10. Europe Ultrasound Therapy Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. Germany
          10.2.2. U.K         
          10.2.3. France
          10.2.4. Italy
          10.2.5. Spain
          10.2.6. Russia
          10.2.7. Poland
          10.2.7. Rest of Europe
    10.3. Market Size (USD Million) Forecast for Europe 2022-2028

11. Asia Pacific Ultrasound Therapy Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Japan
          11.2.2. China
          11.2.3. India
          11.2.4. Australia and New Zealand
          11.2.5. ASEAN
          11.2.6. Rest of Asia Pacific
    11.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

12. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. GCC
          12.2.2. Israel
          12.2.3. South Africa
          12.2.4. Rest of MEA
    12.3. Market Size (USD Million) Forecast for MEA 2022-2028

13. Market Share Analysis and Competitive Landscape   
    13.1. Global Landscape - Key Players, Revenue and Presence
    13.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    13.3. Global Emerging Companies
    13.4. North America - Market Share Analysis and Key Regional Players
    13.5. Europe - Market Share Analysis and Key Regional Players
    13.6. Asia Pacific - Market Share Analysis and Key Regional Players
    13.7. Global Key Player - Growth Matrix

14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    14.1. Chongqing Haifu Medical Technology Co., Ltd.
          14.1.1. Company Overview
          14.1.2. Product Portfolio
          14.1.3. SWOT Analysis
          14.1.4. Financial Overview
          14.1.5. Strategic Overview
    14.2. EDAP TMS S.A.
          14.2.1. Company Overview
          14.2.2. Product Portfolio
          14.2.3. SWOT Analysis
          14.2.4. Financial Overview
          14.2.5. Strategic Overview 
    14.3. SonaCare Medical
          14.3.1. Company Overview
          14.3.2. Product Portfolio
          14.3.3. SWOT Analysis
          14.3.4. Financial Overview
          14.3.5. Strategic Overview
    14.4. ILJIN Holdings Co., Ltd. (ALPINION MEDICAL SYSTEMS Co., Ltd.)
          14.4.1. Company Overview
          14.4.2. Product Portfolio
          14.4.3. SWOT Analysis
          14.4.4. Financial Overview
          14.4.5. Strategic Overview
    14.5. Image Guided Therapy S.A.
          14.5.1. Company Overview
          14.5.2. Product Portfolio
          14.5.3. SWOT Analysis
          14.5.4. Financial Overview
          14.5.5. Strategic Overview          
    14.6. Theraclion SA
          14.6.1. Company Overview
          14.6.2. Product Portfolio
          14.6.3. SWOT Analysis
          14.6.4. Financial Overview
          14.6.5. Strategic Overview      
    14.7. Novartis AG (NAG)
          14.7.1. Company Overview
          14.7.2. Product Portfolio
          14.7.3. SWOT Analysis
          14.7.4. Financial Overview
          14.7.5. Strategic Overview
    14.8. Merz Pharmaceuticals GmbH (Ulthera, Inc.)
          14.8.1. Company Overview
          14.8.2. Product Portfolio
          14.8.3. SWOT Analysis
          14.8.4. Financial Overview
          14.8.5. Strategic Overview
    14.9. Shanghai A&S Technology Development Co., Ltd
          14.9.1. Company Overview
          14.9.2. Product Portfolio
          14.9.3. SWOT Analysis
          14.9.4. Financial Overview
          14.9.5. Strategic Overview
  
15. Pre and Post COVID-19 Impact
    15.1. Positive influence on the healthcare industry
    15.2. The financial disruption of the manufacturing sector
    15.3. Impact of COVID-19 on emerging companies
    15.4. Significant mandates in the healthcare regulations initiated by administrations
    15.5. The overall economic slowdown of the developing and developed nations

16. FutureWise SME Key Takeaway Points for Client

Tables

Figures